Norgine B.V. Acquires Azanta A/S, Strengthening Its Position as a Leading European Specialist Pharmaceutical Company
Amsterdam (ots/PRNewswire) - Norgine B.V. ("Norgine") announces the acquisition of Azanta A/S, a specialty biopharmaceutical company operating within women's healthcare, addiction medicine and oncology. Azanta becomes a wholly-owned subsidiary of Norgine. To view the Multimedia News Release, please click: ...